NCT07380191

Brief Summary

Renal nutrition Fluid control Safe physical activity Sleep hygiene, energy and managing fatigue Adherence and awareness

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
10mo left

Started Mar 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress13%
Mar 2026Mar 2027

First Submitted

Initial submission to the registry

January 15, 2026

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 2, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

March 21, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 22, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2027

Last Updated

February 2, 2026

Status Verified

January 1, 2026

Enrollment Period

9 months

First QC Date

January 15, 2026

Last Update Submit

January 23, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Risk of Falling Assessed by Timed Up and Go Test (TUG)

    Change in risk of falling measured using the Timed Up and Go (TUG) test, recorded in seconds. Lower scores indicate better functional mobility and reduced fall risk.

    Baseline and after 12 weeks of intervention

  • Balance Performance Assessed by Berg Balance Scale (BBS)

    Change in static and dynamic balance measured using the Berg Balance Scale (BBS), scored from 0 to 56 points, with higher scores indicating better balance performance.

    Baseline and after 12 weeks

  • Lower Limb Muscle Strength

    Change in lower limb muscle strength measured using a hand-held dynamometer, recorded in kilograms (kg).

    Baseline and after 12 weeks

Secondary Outcomes (2)

  • Physical Activity Level

    Baseline and after 12 weeks

  • Kidney Disease-Related Quality of Life

    Baseline and after 12 weeks

Other Outcomes (1)

  • Adherence to Intervention Program

    Throughout the 12-week intervention period

Study Arms (2)

BlazePod Training plus Lifestyle Education

EXPERIMENTAL

Participants in this arm will receive an interactive sensorimotor training program using the BlazePod system combined with a structured lifestyle education program. BlazePod training will focus on improving balance, reaction time, coordination, and functional mobility through static and dynamic balance tasks, reactive stepping, and lower-limb coordination exercises. Training sessions will be conducted three times per week for 30 minutes over a period of 12 weeks under the supervision of a physical therapist. In addition, participants will attend a weekly lifestyle education session addressing renal nutrition, fluid management, safe physical activity, fall prevention strategies, sleep hygiene, fatigue management, and medication adherence.

Device: Neuromuscular Electrical Stimulation (NMES)

Tens plus Lifestyle Education

ACTIVE COMPARATOR

Participants in this arm will receive neuromuscular electrical stimulation (NMES) applied to the lower limb muscles, including bilateral quadriceps and hamstrings, combined with the same structured lifestyle education program as the experimental group. NMES will be delivered using a portable electrical stimulation device with parameters adjusted to produce visible and comfortable muscle contractions. Sessions will be conducted three times per week for 30 minutes over 12 weeks under physical therapist supervision. Lifestyle education sessions will be provided once weekly and will include renal nutrition, fluid control, safe physical activity, fall prevention strategies, sleep hygiene, fatigue management, and medication adherence.

Device: Device + BehavioralDevice: Neuromuscular Electrical Stimulation (NMES)

Interventions

This intervention consists of interactive sensorimotor training using the BlazePod system, a visual stimulus-based device designed to improve balance, coordination, reaction time, and functional mobility. Participants will perform static and dynamic balance exercises, reactive stepping drills, lower-limb coordination tasks, and dual-task activities in response to visual cues emitted by the BlazePod sensors. Training sessions will be conducted three times per week, with each session lasting 30 minutes, over a total duration of 12 weeks. All sessions will be supervised by a licensed physical therapist to ensure safety and appropriate progression of exercise difficulty. The intervention aims to reduce fall risk by enhancing neuromuscular control and postural stability in hemodialysis patients.

Tens plus Lifestyle Education

This intervention involves the application of neuromuscular electrical stimulation to the lower limb muscles, specifically the bilateral quadriceps and hamstrings, using a portable electrical stimulation device. Surface electrodes will be placed over the motor points to elicit visible and comfortable muscle contractions. Stimulation parameters will include a frequency of 35-50 Hz, pulse width of 200-400 microseconds, and a duty cycle of 10 seconds on and 30 seconds off. Sessions will be administered three times per week for 30 minutes over 12 weeks under the supervision of a physical therapist. The intervention aims to improve muscle strength, balance, functional mobility, and reduce fall risk in hemodialysis patients.

BlazePod Training plus Lifestyle EducationTens plus Lifestyle Education

Eligibility Criteria

Age40 Years - 50 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male patients aged 40 to 50 years.
  • Diagnosed with end-stage renal disease and receiving maintenance hemodialysis for at least 6 months.
  • Medically stable and cleared by a nephrologist to participate in physical activity and/or electrical stimulation.
  • Able to ambulate independently or with minimal assistance.
  • Cognitively able to understand study procedures.
  • Not participating in any other structured exercise program.

You may not qualify if:

  • Severe neurological or orthopedic disorders affecting mobility.
  • Unstable cardiovascular conditions.
  • Cognitive impairment or sensory deficits.
  • Contraindications to neuromuscular electrical stimulation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta

Tanta, Alquarbia, 31111, Egypt

Location

Related Links

Central Study Contacts

Samia Wagdy El said Diab, PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Application of PlazePod Device and Electrical Stimulation for 60 patients each group 30 for 3months for 40-50age Additionally life style education program, such as: Renal nutrition Fluid control Safe physical activity Sleep hygiene, energy and managing fatigue Adherence and awareness For 3 months, there was one session every week, lasting 30 minutes
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Application two Devices of PlazePod Device and Electrical Stimulation for 60 patients each group 30 for 3months for 40-50age Additionally life style education program, such as: Renal nutrition Fluid control Safe physical activity Sleep hygiene, energy and managing fatigue Adherence and awareness For 3 months, there was one session every week, lasting 30 minutes and comparison between two groups
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
EFFECT OF PLAZEPOD VERSUS ELECTRICAL STIMULATION ON RISK OF FALLING IN HEMODIALYSIS PATIENTS

Study Record Dates

First Submitted

January 15, 2026

First Posted

February 2, 2026

Study Start

March 21, 2026

Primary Completion (Estimated)

December 22, 2026

Study Completion (Estimated)

March 22, 2027

Last Updated

February 2, 2026

Record last verified: 2026-01

Locations